07 Jan 2001

Dayamineral jarabe - España

Updated: 07 Jan 2001

Dayamineral jarabe jarabe 125 ml

Profilaxis y tratamiento de estados carenciales de vitaminas y minerales: Embarazo, lactancia, astenia, crecimiento, etc.

Dayamineral jarabe Description, Presentation and Dosage

Dayamineral jarabe Description

Dayamineral jarabe Drug Class Description

Polivitaminicos con minerales

Dayamineral jarabe Drug Description

JARABE

Dayamineral jarabe Presentation

Dayamineral jarabe Presentation

Lactantes: 1/2 cucharadita/día. Niños: 1 cucharadita/día. Adultos: 2 cucharaditas/día.

Dayamineral jarabe Manufacturer

ABBOTT LABORATORIES

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Dayamineral jarabe Dosage

Dayamineral jarabe Precautions, Reactions and Contraindications

Dayamineral jarabe Special Precautions

Related Drugs - Gastroenterologia

Back to top